PHAT - Phathom Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PHAT is currently covered by 3 analysts with an average price target of $23.4. This is a potential upside of $12.35 (111.76%) from yesterday's end of day stock price of $11.05.

Phathom Pharmaceuticals's activity chart (see below) currently has 74 price targets and 72 ratings on display. The stock rating distribution of PHAT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.96% with an average time for these price targets to be met of 33.22 days.

Highest price target for PHAT is $28, Lowest price target is $12, average price target is $20.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 09-Jun-2025.

Currently out of the existing stock ratings of PHAT, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$20

$7.79 (63.80%)

$20

3 months 29 days ago
(09-Jun-2025)

0/8 (0%)

$11.17 (126.50%)

Buy

$28

$15.79 (129.32%)

$28

4 months 2 days ago
(06-Jun-2025)

0/44 (0%)

$19.08 (213.90%)

Buy

$12

$-0.21 (-1.72%)

5 months 6 days ago
(02-May-2025)

2/7 (28.57%)

$9.24 (334.78%)

134

Hold

$12

$-0.21 (-1.72%)

$10

1 years 1 months 29 days ago
(09-Aug-2024)

6/7 (85.71%)

$0.25 (2.13%)

29

Buy

$30

$17.79 (145.70%)

$35

2 years 7 months 7 days ago
(01-Mar-2023)

0/4 (0%)

$20.99 (232.96%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?

On average it took 33.22 days on average for the stock forecasts to be realized with a an average price target met ratio 21.96

Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

YATIN SUNEJA

Which analyst has the current lower performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 6 ratings on PHAT

Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?

Prakhar Agrawal with highest potential upside - $52.74

Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?

Paul Choi with lowest potential downside - -$0.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?